Coformulation of pembrolizumab and vibostolimab in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort G.

Authors :: Fong, Peter C.C.
Kwiatkowski, Mariusz
Mosca, Alessandra
Perez Valderrama, Begona
Huang, Yi-Hsiu
Zedan, Ahmed H.
Kuc, Kamil
Wiechno, Pawel
Laguerre, Brigitte
Gonzalez-Billalabeitia, Enrique
Osipov, Mikhail
Sener Dede, Didem
Goh, Jeffrey
Daugaard, Gedske
Zhu, Pengfei
Imai, Kentaro
liu, yingjie
Arranz Arija, Jose Angel
Source :: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p149-149, 235p
Publication Year :: 2024

Full Text Access

Tools